These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

767 related articles for article (PubMed ID: 17785058)

  • 21. Prospective, randomized, multicentric, open, comparative study on the efficacy of a prophylactic single dose of 500 mg levofloxacin versus 1920 mg trimethoprim/sulfamethoxazole versus a control group in patients undergoing TUR of the prostate.
    Wagenlehner FM; Wagenlehner C; Schinzel S; Naber KG;
    Eur Urol; 2005 Apr; 47(4):549-56. PubMed ID: 15774257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluation of antibiotic prophylaxis in neutropenic patients with hematologic malignancies].
    Delarive P; Baumgartner JD; Glauser MP; Cometta A
    Schweiz Med Wochenschr; 2000 Dec; 130(48):1837-44. PubMed ID: 11132527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit.
    Craig M; Cumpston AD; Hobbs GR; Devetten MP; Sarwari AR; Ericson SG
    Bone Marrow Transplant; 2007 Apr; 39(8):477-82. PubMed ID: 17322937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prophylaxis with ciprofloxacin in postchemotherapy neutropenia in acute myeloid leukemia].
    López A; Soler JA; Juliá A; Novo A; Bueno J
    Med Clin (Barc); 1994 Jan; 102(3):81-5. PubMed ID: 8133717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ciprofloxacin in treatment of fever and neutropenia in pediatric cancer patients.
    Mullen CA
    Pediatr Infect Dis J; 2003 Dec; 22(12):1138-42. PubMed ID: 14688588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rational selection of patients for antibacterial prophylaxis after chemotherapy.
    Cullen MH; Billingham LJ; Gaunt CH; Steven NM
    J Clin Oncol; 2007 Oct; 25(30):4821-8. PubMed ID: 17947731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of antibacterial prophylaxis for patients with neutropenia. Australian Consensus Guidelines 2011 Steering Committee.
    Slavin MA; Lingaratnam S; Mileshkin L; Booth DL; Cain MJ; Ritchie DS; Wei A; Thursky KA;
    Intern Med J; 2011 Jan; 41(1b):102-9. PubMed ID: 21272174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibiotic prophylaxis in chemotherapy-induced neutropenia: time to reconsider.
    Lo N; Cullen M
    Hematol Oncol; 2006 Sep; 24(3):120-5. PubMed ID: 16783844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Moxifloxacin prophylaxis in neutropenic patients.
    von Baum H; Sigge A; Bommer M; Kern WV; Marre R; Döhner H; Kern P; Reuter S
    J Antimicrob Chemother; 2006 Oct; 58(4):891-4. PubMed ID: 16880172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemotherapy treatment in pediatric patients with acute myeloid leukemia receiving antimicrobial prophylaxis leads to a relative increase of colonization with potentially pathogenic bacteria in the gut.
    van Vliet MJ; Tissing WJ; Dun CA; Meessen NE; Kamps WA; de Bont ES; Harmsen HJ
    Clin Infect Dis; 2009 Jul; 49(2):262-70. PubMed ID: 19514856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibacterial prophylaxis in patients with cancer and neutropenia.
    Pasqualotto AC; Rosa DD; Machado AL
    N Engl J Med; 2006 Jan; 354(1):90-4; author reply 90-4. PubMed ID: 16395830
    [No Abstract]   [Full Text] [Related]  

  • 32. Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: a randomized trial.
    Hou MC; Lin HC; Liu TT; Kuo BI; Lee FY; Chang FY; Lee SD
    Hepatology; 2004 Mar; 39(3):746-53. PubMed ID: 14999693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mucocutaneous findings in febrile neutropenic children with acute leukemias.
    Wananukul S; Nuchprayoon I; Siripanich H
    J Med Assoc Thai; 2005 Jun; 88(6):817-23. PubMed ID: 16083222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The incidence of fluoroquinolone resistant infections after prostate biopsy--are fluoroquinolones still effective prophylaxis?
    Feliciano J; Teper E; Ferrandino M; Macchia RJ; Blank W; Grunberger I; Colon I
    J Urol; 2008 Mar; 179(3):952-5; discussion 955. PubMed ID: 18207185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluoroquinolone prophylaxis in patients with neutropenia.
    Zinner SH
    Clin Infect Dis; 2005 Apr; 40(8):1094-5. PubMed ID: 15791506
    [No Abstract]   [Full Text] [Related]  

  • 36. Infections caused by viridans streptococci in patients with neutropenia.
    Tunkel AR; Sepkowitz KA
    Clin Infect Dis; 2002 Jun; 34(11):1524-9. PubMed ID: 12015700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Infectious complication in 314 patients after high-dose therapy and autologous hematopoietic stem cell transplantation: risk factors analysis and outcome.
    Gil L; Styczynski J; Komarnicki M
    Infection; 2007 Dec; 35(6):421-7. PubMed ID: 17926001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prophylaxis and treatment of bacterial infections: do we need new strategies?
    Micozzi A; Bucaneve G
    Rev Clin Exp Hematol; 2005 Dec; 9(2):E4. PubMed ID: 16864118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of fluoroquinolone-resistant Escherichia coli before and incidence of acute bacterial prostatitis after prostate biopsy.
    Minamida S; Satoh T; Tabata K; Kimura M; Tsumura H; Kurosaka S; Matsumoto K; Fujita T; Iwamura M; Baba S
    Urology; 2011 Dec; 78(6):1235-9. PubMed ID: 21908030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparison of Tarivid and Biseptol in the prevention of bacterial infections in patients with acute leukemia].
    Mociková K; Svác J; Faber E; Wildová B; Baníková I
    Vnitr Lek; 1992 Feb; 38(2):166-72. PubMed ID: 1595205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.